G protein-coupled receptor interactions and modification of signalling involving the ghrelin receptor, GHSR1a
Mitchell Ty Ringuet1, John Barton Furness1,2, Sebastian George Barton Furness3
1Department of Anatomy and Physiology, University of Melbourne, Parkville, VIC, Australia.
Abstract:
The growth hormone secretagogue receptor 1a (GHSR1a) is intriguing because of its potential as a therapeutic target and its diverse molecular interactions. Initial studies of the receptor focused on the potential therapeutic ability for growth hormone (GH) release to reduce wasting in aging individuals, as well as food intake regulation for treatment of cachexia. Known roles of GHSR1a now extend to regulation of neurogenesis, learning and memory, gastrointestinal motility, glucose/lipid metabolism, the cardiovascular system, neuronal protection, motivational salience, and hedonic feeding. Ghrelin, the endogenous agonist of GHSR1a, is primarily located in the stomach and is absent from the central nervous system (CNS), including the spinal cord. However, ghrelin in the circulation does have access to a small number of CNS sites, including the arcuate nucleus, which is important in feeding control. At some sites, such as at somatotrophs, GHSR1a has high constitutive activity. Typically, ghrelin-dependent and constitutive GHSR1a activation occurs via Gαq/11 pathways. In vitro and in vivo data suggest that GHSR1a heterodimerises with multiple G protein-coupled receptors (GPCRs), including dopamine D1 and D2, serotonin 2C, orexin, oxytocin and melanocortin 3 receptors (MCR3), as well as the MCR3 accessory protein, MRAP2, providing possible mechanisms for its many physiological effects. In all cases, the receptor interaction changes downstream signalling and the responses to receptor agonists. This review discusses the signalling mechanisms of GHSR1a alone and in combination with other GPCRs, and explores the physiological consequences of GHSR1a coupling with other GPCRs.
Insights
The growth hormone secretagogue receptor 1a (GHSR1a) plays diverse roles beyond GH release, including neurogenesis and metabolism. Its interactions with other receptors reveal complex signaling pathways and physiological effects.
Area of Science:
- Neuroendocrinology
- Molecular Pharmacology
- GPCR Signaling
Background:
- The growth hormone secretagogue receptor 1a (GHSR1a) has known roles in growth hormone release and appetite regulation.
- Emerging evidence implicates GHSR1a in neurogenesis, learning, memory, metabolism, and cardiovascular function.
- Ghrelin, the endogenous GHSR1a agonist, is mainly gastric but influences the CNS via circulation.
Purpose of the Study:
- To review the signaling mechanisms of GHSR1a.
- To explore the physiological consequences of GHSR1a interactions with other G protein-coupled receptors (GPCRs).
Main Methods:
- In vitro and in vivo studies were analyzed.
- Literature review of GHSR1a signaling and heterodimerization with other GPCRs.
Main Results:
- GHSR1a activation typically involves Gαq/11 pathways.
- GHSR1a forms heterodimers with various GPCRs (e.g., dopamine, serotonin, orexin, oxytocin, MCR3) and MRAP2.
- Receptor interactions modulate downstream signaling and agonist responses.
Conclusions:
- GHSR1a exhibits complex signaling through homo- and heterodimerization.
- These interactions contribute to the receptor's wide-ranging physiological effects.
- Understanding these mechanisms is crucial for therapeutic targeting.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G-protein Coupled Receptors
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Activation and Inactivation of G Proteins
GPCR Desensitization


